U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07673120) titled 'A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants' on June 23.
Brief Summary: The objective of this study is to assess the safety, tolerability, pharmacokinetics, and immunogenicity of single and multiple doses of ABBV-313 in healthy adult participants.
Study Start Date: June 22
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: ABBV-313
Injection
DRUG: Placebo
Injection
DRUG: ABBV-313
Infusion
DRUG: Placebo
Infusion
Recruitment Status: RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Servi...